This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: S Andor Farkas: Innovator in Pharmaceutical Compositions
Introduction
S Andor Farkas is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzodiazepine derivatives. His research focuses on developing compounds that can have valuable effects on the central nervous system.
Latest Patents
Farkas holds a patent for "N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions." This invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers, and acid-addition salts. The pharmaceutical compositions containing these compounds are designed for a process of preparation that enhances their efficacy. The compounds possess valuable central nervous system effects, including muscle-relaxant, anticonvulsive, and neuroprotective actions. Thus, they may be useful for treating various diseases of central nervous system origin. He has 1 patent to his name.
Career Highlights
Farkas is associated with Gyogyszerkutato Intezet Kft., where he continues to contribute to pharmaceutical research and development. His work has been instrumental in advancing the understanding of benzodiazepine derivatives and their potential applications in medicine.
Collaborations
Some of his notable coworkers include Ferenc Andr Asi and P Al Berzsenyi. Their collaborative efforts have further enriched the research environment and have led to advancements in their respective fields.
Conclusion
S Andor Farkas is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of central nervous system disorders. His innovative approach and dedication to research continue to pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile